Evidence map›Paper›PMID 26071043›Full record

SynthesisSystematic reviews2015

Managing the incidence of selective reporting bias: a survey of Cochrane review groups.

Emma K Reid, Aaron M Tejani, Lawrence N Huan, Gregory Egan, Cait O'Sullivan, Alain D Mayhew, Monisha Kabir

Abstract readSystematic Review
In one paragraph

Synthesis in Systematic reviews, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Emma K ReidPharmaceutical Sciences, Vancouver General Hospital, 855 West 12th Avenue, Vancouver, BC, V5Z 1M9, Canada. emma.reid@vch.ca.
Aaron M TejaniTherapeutics Initiative (Faculty of Medicine), University of British Columbia, 2176 Health Sciences Mall, Vancouver, BC, V6T 1Z3, Canada. aaron.tejani@ti.ubc.ca.
Lawrence N HuanDepartment of Pharmacy, Richmond General Hospital, 7000 Westminster Highway, Richmond, BC, V6X 1A2, Canada. lawrence.huan@vch.ca.
Gregory EganPharmaceutical Sciences, Vancouver General Hospital, 855 West 12th Avenue, Vancouver, BC, V5Z 1M9, Canada. gregory.egan@vch.ca.
Cait O'SullivanIsland Health Clinical Pharmacy Programs, 375 Second Avenue, Campbell River, BC, V9W 3V1, Canada. cait.osullivan@viha.ca.
Alain D MayhewKnowledge Synthesis Group, Cochrane Methods-Bias, Ottawa Hospital Research Institute, 501 Smyth Road, Ottawa, ON, K1H 8L6, Canada. almayhew@ohri.ca.
Monisha KabirDepartment of Biology, University of Ottawa, 75 Laurier Ave E, Ottawa, ON, K1N 6N5, Canada. mkabi060@uottawa.ca.

Funding

Canadian Institutes of Health Research CON-105529
6 · The paper itself

Abstract

backgroundSelective reporting bias (SRB), the incomplete publication of outcomes measured or of analyses performed in a study, may lead to the over- or underestimation of treatment effects or harms. Cochrane systematic reviews of interventions are required to assess the risk of SRB, achieved in part by applying the Cochrane risk of bias tool to each included randomised trial. The Cochrane Handbook outlines strategies for a comprehensive risk of bias assessment, but the extent to which these are followed by Cochrane review groups (CRGs) has not been assessed to date. The objective of this study was to determine the methods which CRGs require of their authors to address SRB within systematic reviews, and how SRB risk assessments are verified.

methodsA cross-sectional survey was developed and distributed electronically to the 52 CRGs involved in intervention reviews.

resultsResponses from 42 CRGs show that the majority refer their authors to the Cochrane Handbook for specific instruction regarding assessments of SRB. The handbook strategies remain variably enforced, with 57 % (24/42) of CRGs not requiring review authors to search for included trial protocols and 31 % (13/42) not requiring that contact with individual study authors be attempted. Only half (48 %, 20/42) of the groups consistently verify review authors' assessments of the risk of SRB to ensure completeness.

conclusionsA range of practices are used by CRGs for addressing SRB, with many steps outlined in the Cochrane Handbook being encouraged but not required. The majority of CRGs do not consider their review authors to be sufficiently competent to assess for SRB, yet risk of bias assessments are not always verified by editors before publication. The implications of SRB may not be fully appreciated by all CRGs, and resolving the identified issues may require an approach targeting several steps in the systematic review process.

Indexed as

BiasPublishingReview Literature as TopicSurveys and QuestionnairesCross-Sectional StudiesHumansIncidenceRandomized Controlled Trials as Topic

Identifiers

PMID26071043
PMCPMC4472158

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.